126 related articles for article (PubMed ID: 8261220)
1. Platelet-derived growth factor is released into the coronary circulation after coronary spasm.
Ogawa H; Yasue H; Okumura K; Fujii H; Masuda T; Miyao Y; Bannai S; Takanashi N
Coron Artery Dis; 1993 May; 4(5):437-42. PubMed ID: 8261220
[TBL] [Abstract][Full Text] [Related]
2. Fibrinopeptide A is released into the coronary circulation after coronary spasm.
Oshima S; Yasue H; Ogawa H; Okumura K; Matsuyama K
Circulation; 1990 Dec; 82(6):2222-5. PubMed ID: 2146992
[TBL] [Abstract][Full Text] [Related]
3. Soluble P-selectin is released into the coronary circulation after coronary spasm.
Kaikita K; Ogawa H; Yasue H; Sakamoto T; Suefuji H; Sumida H; Okumura K
Circulation; 1995 Oct; 92(7):1726-30. PubMed ID: 7545553
[TBL] [Abstract][Full Text] [Related]
4. Heparin-releasable endothelial cell-associated tissue factor pathway inhibitor (TFPI) is increased in the coronary circulation after coronary spasm in patients with coronary spastic angina.
Nishiyama K; Ogawa H; Yasue H; Soejima H; Misumi K; Kugiyama K; Tsuji I; Kumeda K
Thromb Res; 1998 Feb; 89(3):137-46. PubMed ID: 9622042
[TBL] [Abstract][Full Text] [Related]
5. Enhanced platelet aggregation in the coronary circulation after coronary spasm.
Miyamoto S; Ogawa H; Soejima H; Takazoe K; Kajiwara I; Shimomura H; Sakamoto T; Yoshimura M; Kugiyama K; Yasue H; Ozaki Y
Thromb Res; 2001 Sep; 103(5):377-86. PubMed ID: 11553370
[TBL] [Abstract][Full Text] [Related]
6. Increase in plasma levels of secretory type II phospholipase A(2) in patients with coronary spastic angina.
Kugiyama K; Ota Y; Kawano H; Soejima H; Ogawa H; Sugiyama S; Doi H; Yasue H
Cardiovasc Res; 2000 Jul; 47(1):159-65. PubMed ID: 10869542
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina.
Matsuyama K; Yasue H; Okumura K; Saito Y; Nakao K; Shirakami G; Imura H
Am J Cardiol; 1991 Oct; 68(10):991-5. PubMed ID: 1927939
[TBL] [Abstract][Full Text] [Related]
8. Plasma platelet-derived growth factor levels in coronary circulation in unstable angina pectoris.
Ogawa H; Yasue H; Misumi I; Masuda T; Okumura K; Bannai S; Takanashi N; Tsukada Y
Am J Cardiol; 1992 Feb; 69(5):453-6. PubMed ID: 1736605
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris.
Montalescot G; Drobinski G; Maclouf J; Maillet F; Salloum J; Ankri A; Kazatchkine M; Eugène L; Thomas D; Grosgogeat Y
Circulation; 1991 Nov; 84(5):2054-62. PubMed ID: 1934381
[TBL] [Abstract][Full Text] [Related]
10. Biphasic changes (initial increase and late decrease) in coronary sinus venous oxygen saturation during anginal attacks induced by intracoronary acetylcholine in patients with variant angina.
Miwa K; Fujita M; Ejiri M; Sasayama S
Cardiology; 1992; 81(4-5):221-32. PubMed ID: 1301247
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries).
Ong P; Athanasiadis A; Borgulya G; Mahrholdt H; Kaski JC; Sechtem U
J Am Coll Cardiol; 2012 Feb; 59(7):655-62. PubMed ID: 22322081
[TBL] [Abstract][Full Text] [Related]
12. Consumption of vitamin E in coronary circulation in patients with variant angina.
Miwa K; Igawa A; Nakagawa K; Hirai T; Inoue H
Cardiovasc Res; 1999 Jan; 41(1):291-8. PubMed ID: 10325977
[TBL] [Abstract][Full Text] [Related]
13. New combined spasm provocation test in patients with rest angina: intracoronary injection of acetylcholine after intracoronary administration of ergonovine.
Sueda S; Ochi T; Yano K; Mineoi K; Kondou T; Ochi N; Hayashi Y; Kukita H; Matsuda S; Kawada H; Tsuruoka T; Uraoka T
Jpn Circ J; 2000 Aug; 64(8):559-65. PubMed ID: 10952150
[TBL] [Abstract][Full Text] [Related]
14. Comparative sensitivity of intracoronary injection of acetylcholine for the induction of coronary spasm in patients with various types of angina pectoris.
Miwa K; Fujita M; Ejiri M; Sasayama S
Am Heart J; 1990 Sep; 120(3):544-50. PubMed ID: 2117844
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholine-induced coronary spasm in patients with unobstructed coronary arteries is associated with elevated concentrations of soluble CD40 ligand and high-sensitivity C-reactive protein.
Ong P; Carro A; Athanasiadis A; Borgulya G; Schäufele T; Ratge D; Gaze D; Sechtem U; Kaski JC
Coron Artery Dis; 2015 Mar; 26(2):126-32. PubMed ID: 25405929
[TBL] [Abstract][Full Text] [Related]
16. Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina.
Watanabe K; Takahashi T; Miyajima S; Hirokawa Y; Tanabe N; Kato K; Kodama M; Aizawa Y; Tazawa S; Inoue M
J Nucl Med; 2002 Nov; 43(11):1476-81. PubMed ID: 12411551
[TBL] [Abstract][Full Text] [Related]
17. Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina.
Miwa K; Igawa A; Inoue H
Cardiovasc Res; 1997 Oct; 36(1):37-44. PubMed ID: 9415270
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina.
Kugiyama K; Yasue H; Okumura K; Ogawa H; Fujimoto K; Nakao K; Yoshimura M; Motoyama T; Inobe Y; Kawano H
Circulation; 1996 Aug; 94(3):266-71. PubMed ID: 8759065
[TBL] [Abstract][Full Text] [Related]
19. Angina pectoris caused by coronary microvascular spasm.
Mohri M; Koyanagi M; Egashira K; Tagawa H; Ichiki T; Shimokawa H; Takeshita A
Lancet; 1998 Apr; 351(9110):1165-9. PubMed ID: 9643687
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris.
Toyo-oka T; Aizawa T; Suzuki N; Hirata Y; Miyauchi T; Shin WS; Yanagisawa M; Masaki T; Sugimoto T
Circulation; 1991 Feb; 83(2):476-83. PubMed ID: 1825037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
